Heritage Wealth Advisors Biogen Inc. Transaction History

Heritage Wealth Advisors

$2.06 Billion
Q3 2024

A detailed history of Heritage Wealth Advisors transactions in Biogen Inc. stock. As of the latest transaction made, Heritage Wealth Advisors holds 2,000 shares of BIIB stock, worth $319,660. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,000

Previous 2,000 -0.0%

Holding current value

$319,660

Previous $463,000 16.41%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $2,120 - $2,677	-10 Reduced 0.5%	2,000 $431,000
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $2,225 - $2,679	10 Added 0.5%	2,010 $520,000
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $8,209 - $9,354	-32 Reduced 1.57%	2,000 $556,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $17,439 - $21,972	-90 Reduced 4.24%	2,032 $428,000
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $25,123 - $40,226	-97 Reduced 4.37%	2,122 $734,000
Q2 2021 Jul 27, 2021	BUY	$259.0 - $414.71 $9,583 - $15,344	37 Added 1.7%	2,219 $543,000
Q1 2021 Apr 27, 2021	SELL	$242.95 - $284.63 $8,989 - $10,531	-37 Reduced 1.67%	2,182 $610,000
Q4 2020 Feb 01, 2021	SELL	$236.26 - $355.63 $39,691 - $59,745	-168 Reduced 7.04%	2,219 $543,000
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $11,120 - $12,839	42 Added 1.79%	2,387 $677,000
Q2 2020 Jul 17, 2020	SELL	$258.66 - $342.55 $540,599 - $715,929	-2,090 Reduced 91.27%	200 $627,000
Q2 2020 Jul 17, 2020	BUY	$258.66 - $342.55 $554,825 - $734,769	2,145 Added 1072.5%	2,345 $627,000
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $7,527 - $9,549	28 Added 1.24%	2,290 $724,000
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $7,041 - $9,730	32 Added 1.43%	2,262 $671,000
Q3 2019 Oct 30, 2019	BUY	$217.44 - $243.88 $2,609 - $2,926	12 Added 0.54%	2,230 $519,000
Q2 2019 Aug 05, 2019	BUY	$219.29 - $241.72 $21,929 - $24,172	100 Added 4.72%	2,218 $0
Q4 2018 Jan 28, 2019	SELL	$278.5 - $352.75 $4,177 - $5,291	-15 Reduced 0.7%	2,118 $637,000
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $1,040 - $1,471	4 Added 0.19%	2,133 $584,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $14,459 - $16,195	47 Added 2.26%	2,129 $679,000
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $585,354 - $686,414	2,082	2,082 $652,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.

Account

Heritage Wealth Advisors Biogen Inc. Transaction History